We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A Translational Perspective – Biacore Systems in Discovery and Early-Stage Development

Therapeutic Antibodies

Translational science has launched a new era of antibody therapeutics, driving demand for novel antibody formats designed to improve the efficacy of therapies and reach new targets. For a smooth molecule journey from benchtop to clinic you need to make the most informed candidate selection and reduce the risk of failure and complications during development.

Cytiva's BiacoreTM systems support informed decision-making during the lead candidate selection process. Its technology delivers valuable insights into developability such as manufacturability and safety.

Download this whitepaper to learn how surface plasmon resonance (SPR) can:

Enhance the drug discovery process for translational scientists

Support informed decision making during the lead candidate selection process 

Reduce the risk of failure and complications during development

Leverage technology to deliver valuable insights into developability — for a smooth journey from benchtop to clinic

Brought to you by
Download Your Whitepaper for FREE Below
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.